Atherosclerotic renovascular disease and the heart

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Vascular Biology

Background:

• Atherosclerotic renovascular disease (ARVD) is strongly associated with cardiac pathophysiology.
• Patients with ARVD frequently exhibit widespread atherosclerotic disease, impacting coronary circulation and leading to prevalent cardiac structural and functional changes.
• This significant cardiovascular burden contributes to increased cardiac morbidity and mortality in ARVD patients.

Purpose of the Study:

• To review the associations between cardiovascular disease and ARVD.
• To discuss current treatment strategies for ARVD and associated cardiovascular complications.
• To explore the potential benefits of renal revascularization on cardiac morphology and function in ARVD patients.

Main Methods:

• Literature review focusing on the interplay between cardiac and renal systems in ARVD.
• Analysis of existing data on cardiovascular disease prevalence and outcomes in ARVD.
• Discussion of the evidence and ongoing research regarding revascularization therapies.

Main Results:

• The link between cardiac and renal pathophysiology in ARVD is well-established.
• Cardiovascular disease is highly prevalent in ARVD patients, contributing to poor cardiac outcomes.
• The efficacy of revascularization versus medication alone for cardiovascular benefits in ARVD remains a subject of clinical debate.

Conclusions:

• The close relationship between cardiac and renal conditions in ARVD suggests potential benefits of renal revascularization for cardiac health.
• Ongoing randomized controlled trials are investigating whether renal revascularization can improve cardiac morphology and function.
• Further research is needed to clarify the role of revascularization in managing ARVD and its cardiovascular sequelae.